Literature DB >> 7472813

Treatment with 8-MOP and UVA enhances MHC class I synthesis in RMA cells: preliminary results.

A C Moor1, I M Schmitt, G M Beijersbergen van Henegouwen, S Chimenti, R L Edelson, F P Gasparro.   

Abstract

The response of psoriasis and cutaneous T-cell lymphoma to treatment with 8-methoxypsoralen (8-MOP) and long wavelength ultraviolet light (UVA) is only partly understood. Psoralens form photoadducts within the DNA after activation by UVA and this damage leads to the inhibition of DNA synthesis. Additionally, it has been shown that different forms of DNA damage can induce a stress response, leading to upregulation of selected products. Among these are the major histocompatibility complex (MHC) class I genes. Thus the aim of the present study was to assess the rate of synthesis of MHC class I proteins in murine T-cell lymphoma cells (RMA) after treatment with 8-MOP and UVA. RMA cells were treated with 8-MOP (50-200 ng ml-1) and UVA (1 J.cm-2) and metabolically labelled with 35S-methionine 4 and 24 h after treatment. MHC class I synthesis was determined by immunoprecipitation of the cell lysates with an anti-Kb monoclonal antibody, Y3. After 4 h, treated and untreated cells demonstrated no differences in the rate of MHC class I synthesis. However, after 24 h a dose-dependent increase in MHC class I synthesis was observed. This increase in MHC class I expression could be responsible, at least partly, for the responses observed in patients treated with photopheresis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7472813     DOI: 10.1016/1011-1344(95)07143-p

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  3 in total

Review 1.  Pruritus in cutaneous T-cell lymphoma: a review.

Authors:  Kristen Ahern; Elaine S Gilmore; Brian Poligone
Journal:  J Am Acad Dermatol       Date:  2012-01-30       Impact factor: 11.527

Review 2.  Cutaneous T-cell lymphoma: Biologic targets for therapy.

Authors:  Jaehyuk Choi; Francine Foss
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

3.  Enhancing Radiation Therapy Through Cherenkov Light-Activated Phototherapy.

Authors:  Suk W Yoon; Vadim Tsvankin; Zachary Shrock; Boyu Meng; Xiaofeng Zhang; Mark Dewhirst; Peter Fecci; Justus Adamson; Mark Oldham
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-11-16       Impact factor: 7.038

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.